FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells

FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells

Chimeric Antigen Receptor T-cells have improved the life expectancy of severely pretreated patients with aggressive hematological cancers; for this reason, therapy-related myeloid leukemias are becoming of great concern in this field, despite their clonal phylogenesis and mutational landscape have...

Full description

Bibliographic Details
Main Authors: Eugenio Galli, Filippo Frioni, Tanja Malara, Enrico Attardi, Silvia Bellesi, Stefan Hohaus, Simona Sica, Federica Sorà, Patrizia Chiusolo
Format: Article
Language:English
Published: Mattioli1885 2024-02-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Therapy-related leukemia
CAR-T cells
B-cell non-Hodgkin's lymphoma
FLT3-ITD
Online Access:https://www.mjhid.org/mjhid/article/view/5622

Internet

https://www.mjhid.org/mjhid/article/view/5622

Similar Items